Pandit-Taskar, Neeta

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs

Bacterial Cancer TherapyAmino Acid Enzymes and Metabolism

Cited by 146

Biodistribution and Dosimetry of 18 F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

Pandit-Taskar, N., Zanzonico, P., Staton, K. D., Carrasquillo, J. A., Reidy-Lagunes, D., Lyashchenko, S., Burnazi, E., Zhang, H., Lewis, J. S., Blasberg, R., et al. (2018) · Journal of Nuclear Medicine

Radiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research Advances

Cited by 136

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan.

Reidy-Lagunes, D., Pandit-Taskar, N., O'Donoghue, J. A., Krebs, S., Staton, K. D., Lyashchenko, S. K., Lewis, J. S., Raj, N., Gönen, M., Lohrmann, C., et al. (2019) · Clinical Cancer Research

Neuroendocrine Tumor Research AdvancesRadiopharmaceutical Chemistry and Applications

Cited by 112

Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging

Pandit-Taskar, N., Zanzonico, P., Hilden, P., Ostrovnaya, I., Carrasquillo, J. A., & Modak, S. (2017) · Clinical Nuclear Medicine

Radiopharmaceutical Chemistry and ApplicationsAdvanced Radiotherapy Techniques

Cited by 22